Slide 1: Q1 2025 Results Investor Presentation
Q1 2025 Results Sustainable Water Solutions Investor Presentation April 30, 2025
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Fluence Corporation Limited (ASX: apply for any securities, including in any jurisdiction where, or to any person FLC). All currencies quoted as “$” are US dollars unless otherwise specified. to whom, such an offer or invitation would be unlawful. Th
Slide 3: Executive Summary
Executive Summary New and Highly • Over 100 years of experience in the water and wastewater treatment industry Experienced • Chairman, CEO, CFO, and CCO all joined within the last 2-3 years Leadership • Notable turnaround experience and a number of highly successful exits leading to material returns
Slide 4: Fluence Business Segments
Fluence Business Segments The water and wastewater treatment market is highly fragmented, offering a direct opportunity for Fluence to focus on high-growth end markets MUNICIPAL WATER & WASTEWATER INDUSTRIAL WASTEWATER & BIOGAS INDUSTRIAL WATER & REUSE SEA ASIA & CHINA • Market-leading MABR technolo
Slide 5: Shifting Focus to SPS and RR
Shifting Focus to SPS and RR Focusing our business on SPS significantly improves profitability, recurring revenue and growth • Stronger focus on SPS: Ramping sales of TRANSITION TO HIGHER MARGIN SEGMENTS our unique, decentralized water and wastewater treatment solutions Illustrative increase in GM%
Slide 6: Fluence's Strategic Transition - Revenue Segmentation
Fluence’s Strategic Transition - Revenue Segmentation Focused on growing presence in North America and transitioning from CES revenue to SPS and RR segments Medium-Term 2022 2023 2024 Q1 2025 TARGETS GEOGRAPHY 11% 6% 9% 13% 12% 8% 13% 6% 27% 33% 30% 19% 7% 10% • Focus on growing 11% 15% 9% presence
Slide 7: Q1 2025 Financial Highlights
Q1 2025 Financial Highlights All numbers subject to audit • Q1 2025 Revenue of $16.6M, representing 64.5% growth over Q1 2024 Financial Summary (FY2022-25F) (2)(3) - SPS plus RR growth of 13.4% (US$ millions) - Ivory Coast Addendum revenue of $5.7M was $5.3M higher than Q1 2024 $116M • Exceeded brea
Slide 8: Recent Orders
Recent Orders The Company secured several notable new orders in Q1 and April 2025, including: • Confidential Dairy Processing Company: Anaerobic Digester (WW-to-energy) – Italy ($2.3M); • Wilshire Road Development: Aspiral MABR (Phase 1 of 3) – 1st MABR water reuse project in California, USA ($2.3M)
Slide 9: Pipeline Growth Continues; Healthy Backlog to Drive Financial Results in FY25
Pipeline Growth Continues; Healthy Backlog to Drive Financial Results in FY25 Investment in sales, particularly in North America, paying dividends through growing pipeline Sales Pipeline Growth (1) (US$ millions) • Pipeline has increased by $283M (+35%) since Q4 2023 and $152M (+16%) since Q1 2024 •
Slide 10: For further information, please contact
www.fluencecorp.com For further information, please contact: Australia United States of America Andrew Angus Thomas Pokorsky Investor Relations CEO and Managing Director E: andrewangus@overlandadvisers.com.au E: tpokorsky@fluencecorp.com P: +61 402 823 757 10